The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2022 | Incidence of hypovitaminosis D in patients with renal AL amyloidosis
Eli Muchtar, MD, Mayo Clinic, Rochester, MN, comments on the incidence and impact of hypovitaminosis D in patients with renal AL amyloidosis. Dr Muchtar explains that hypovitaminosis D is very frequent in this patient population, especially in patients with proteinuria. However, the impact of this deficiency remains unclear. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
